Mots-clés
> MYOBASE > BIOLOGIE > biologie par discipline > génétique > génétique médicale > conseil génétique
conseil génétiqueSynonyme(s)genetic counselling ;génétique conseil ;consultation génétique genetic counseling |
Documents disponibles dans cette catégorie (2118)
Article
Bird TD | 25/04/2024Initial Posting: September 28, 1998; Last Revision: April 25, 2024. The purpose of this overview is to increase the awareness of clinicians regarding Charcot-Marie-Tooth (CMT) hereditary neuropathy, its causes, and its management. The followi[...]Article
Bird TD | 21/03/2024Initial Posting: September 17, 1999; Last Revision: March 21, 2024. Clinical characteristics. Myotonic dystrophy type 1 (DM1) is a multisystem disorder that affects skeletal and smooth muscle as well as the eye, heart, endocrine system, an[...]Article
Article
Moller B ; Coppolla A ; Jungbluth H ; Dafsari HS | Seattle (WA) : University of Washington, Seattle | 14/03/2024CLINICAL CHARACTERISTICS: DYNC1H1-related disorders are primarily characterized by an axonal neuropathy with a wide phenotypic spectrum ranging from a neuromuscular-only phenotype (DYNC1H1-related neuromuscular disorder, or DYNC1H1-NMD) to pheno[...]Article
Beijer D ; Marte S ; Li JC ; De Ridder W ; Chen JZ ; Tadenev ALD ; Miers KE ; Deconinck T ; Macdonell R ; Marques W ; De Jonghe P ; Pratt SL ; Meyer-Schuman R ; Zuchner S ; Antonellis A ; Burgess RW ; Baets J | 08/03/2024Article
Favier M ; Delanne J ; Gorincour G ; Faivre L ; Racine C ; Philippe C ; Duffourd Y ; Vitobello A ; Rousseau T ; Martz O ; Tarris G ; Oualiken C ; Thauvin-Robinet C ; Mau-Them FT | 11/02/2024Article
Zanoteli E ; Araujo APQC ; Becker MM ; Fortes CPDD ; França MC ; Machado-Costa MC ; Marques W ; Matsui C ; Mendonça RH ; Nardes F ; Oliveira ASB ; Pessoa ALS ; Saute JAM ; Sgobbi P ; Van der Linden H ; Gurgel-Giannetti J | 01/2024Article
Altassan R ; AlQudairy H ; AlJebreen S ; AlMuhaizea M ; Al-Hindi H ; Pena-Guerra KA ; Ghebeh H ; Almzroua A ; Albakheet A ; AlDosary M ; Colak D ; Arold ST ; Kaya N | 21/12/2023Article
Initial Posting: August 31, 2007; Last Revision: November 2, 2023. Clinical characteristics. Pompe disease is classified by age of onset, organ involvement, severity, and rate of progression. Infantile-onset Pompe disease (IOPD; indiv[...]Article
Wallace SE ; Gillentine MA | 19/10/2023Initial Posting: December 8, 2022; Last Revision: October 19, 2023. A founder variant is a pathogenic variant observed at high frequency in a specific population due to the presence of the variant in a single ancestor or small number of ances[...]Article
Last Update: August 22, 2023. [Previous version: 2020]Article
Leslie ND ; Saenz-Ayala S | 13/07/2023In: Adam MP, Mirzaa GM, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993 Initial Posting: May 28, 2009; Last Revision: July 13, 2023 (Previous Update: June 16, 2022) CLINICAL CHARACT[...]Article
Sangadala S ; Shore EM ; Xu M ; Bergwitz C ; Lozano-Calderon SA ; Lin AE ; Boden SD ; Kaplan FS | 23/05/2023Article
Article
Article
De Ridder W ; de Vries G ; Van Schil K ; Deconinck T ; Mouly V ; Straub V ; Baets J | England | 07/04/2023Article
Ghaoui R ; Ha TT ; Kerkhof J ; McConkey H ; Gao S ; Babic M ; King R ; Ravenscroft G ; Koszyca B ; Otto S ; Laing NG ; Scott H ; Sadikovic B ; Kassahn KS | 04/04/2023Article
In: Adam MP, Mirzaa GM, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2023. Initial Posting: March 30, 2023. CLINICAL CHARACTERISTICS: CHKB-related muscular dystrophy (CHKB-MD), r[...]Article
Abaji M ; Mignon-Ravix C ; Gorokhova S ; Cacciagli P ; Mortreux J ; Molinari F ; Chabrol B ; Sigaudy S ; Villard L ; Riccardi F | England | 27/03/2023Article
Folland C ; Ganesh V ; Weisburd B ; McLean C ; Kornberg AJ ; O'Donnell-Luria A ; Rehm HL ; Stevanovski I ; Chintalaphani SR ; Kennedy P ; Deveson IW ; Ravenscroft G | United States | 14/03/2023Article
Kramer JJ ; Boon HTM ; Leijten QH ; Ter Laak H ; Eshuis L ; Kusters B ; van Doorn JLM ; Kamsteeg EJ ; Eymard B ; Doorduin J ; Voermans NC | 29/12/2022Article
La Spada A | 15/12/2022Initial Posting: February 26, 1999; Last Update: December 15, 2022. Clinical characteristics. Spinal and bulbar muscular atrophy (SBMA) is a gradually progressive neuromuscular disorder in which degeneration of lower motor neurons results in[...]Article
Granger A ; Beecher G ; Liewluck T ; Nicolau S ; Flanigan KM ; Laughlin RS ; Milone M | England | 15/12/2022Article
Article
Article
Angelini C | 01/12/2022Initial Posting: May 10, 2005; Last Update: December 1, 2022. Clinical characteristics. Calpainopathy is characterized by symmetric and progressive weakness of proximal limb-girdle muscles. Clinical findings of calpainopathy include the tend[...]Article
Article
Article
Hiramuki Y ; Kure Y ; Saito Y ; Ogawa M ; Ishikawa K ; Mori-Yoshimura M ; Oya Y ; Takahashi Y ; Kim DS ; Arai N ; Mori C ; Matsumura T ; Hamano T ; Nakamura K ; Ikezoe K ; Hayashi S ; Goto Y ; Noguchi S ; Nishino I | England | 08/11/2022Article
Reco PNDS
Collectif | 11/2022Ce protocole national de diagnostic et de soins (PNDS) explicite aux professionnels concernés la prise en charge diagnostique et thérapeutique optimale et le parcours de soins des patients atteints de myopathies liées au collagène de type VI (CO[...]Article
Weihl CC ; Topf A ; Bengoechea R ; Duff J ; Charlton R ; Garcia SK ; Dominguez-Gonzalez C ; AlSaman A ; Hernandez Lain A ; Franco LV ; Sanchez MEP ; Beecroft SJ ; Goullee H ; Daw J ; Bhadra A ; True H ; Inoue M ; Findlay AR ; Laing N ; Olive M ; Ravenscroft G ; Straub V | Germany | 20/10/2022Article
Cipriani S ; Guerrero-Valero M ; Tozza S ; Zhao E ; Vollmer V ; Beijer D ; Danzi M ; Rivellini C ; Lazarevic D ; Pipitone GB ; Grosz BR ; Lamperti C ; Marzoli SB ; Carrera P ; Devoto M ; Pisciotta C ; Pareyson D ; Kennerson M ; Previtali SC ; Zuchner S ; Scherer SS ; Manganelli F ; Bähler M ; Bolino A | England | 19/10/2022Article
Pini S ; Napoli FM ; Tagliafico E ; La Marca A ; Bertucci E ; Salsi V ; Tupler R | Denmark | 17/10/2022Article
Ahmad I ; Khan A ; Noor Ul Ayan H ; Budde B ; Altmuller J ; Korejo AA ; Nurnberg G ; Thiele H ; Tariq M ; Nurnberg P ; Erdmann J | England | 11/10/2022Article
Reco PNDS
Collectif | 10/2022Ce protocole national de diagnostic et de soins (PNDS) explicite aux professionnels concernés la prise en charge diagnostique et thérapeutique optimale et le parcours de soins d'un patient atteint de dystrophie musculaire oculopharyngée. Il a ét[...]Reco PNDS
Collectif | 10/2022Ce protocole national de diagnostic et de soins (PNDS) explicite aux professionnels concernés la prise en charge diagnostique et thérapeutique optimale et le parcours de soins d’un malade atteint de laminopathie avec atteinte cardiaque. Il a été[...]Article
Article
Vezain M ; Thauvin-Robinet C ; Vial Y ; Coutant S ; Drunat S ; Urtizberea JA ; Rolland A ; Jacquin-Piques A ; Fehrenbach S ; Nicolas G ; Lecoquierre F ; Saugier-Veber P | Germany | 23/09/2022Article
Article
Morales F ; Corrales E ; Vasquez M ; Zhang B ; Fernandez H ; Alvarado F ; Cortés S ; Santamaria-Ulloa C ; Krahe R ; Monckton DG | England | 13/09/2022Article
Tsai YC ; de Pontual L ; Heiner C ; Stojkovic T ; Furling D ; Bassez G ; Gourdon G ; Tome S | United States | 07/09/2022Article
Article
Article
Article
Cohen G ; Shtorch-Asor A ; Ben Shahar S ; Goldfarb Yaacobi R ; Kaiser M ; Rosenfeld R ; Vinovezky M ; Irge D ; Furman Y ; Reiss D ; Litz Philipsborn S ; Sukenik Halevy R | England | 25/06/2022Article
Article
Genes, 13, 6. Genetic Profile of Patients with Limb-Girdle Muscle Weakness in the Chilean Population
Cerino M ; González-Hormazábal P ; Abaji M ; Courrier S ; Puppo F ; Mathieu Y ; Trangulao A ; Earle N ; Castiglioni C ; Diaz J ; Campero M ; Hughes R ; Vargas C ; Cortes R ; Kleinsteuber K ; Acosta I ; Urtizberea JA ; Levy N ; Bartoli M ; Krahn M ; Jara L ; Caviedes P ; Gorokhova S ; Bevilacqua JA | 06/2022Article
Article
Boon HTM ; Jacobs B ; Wouter VR ; Kamsteeg EJ ; Kuks JBM ; Vincent A ; Eymard B ; Voermans NC | Netherlands | 22/04/2022Article
Pfeffer G ; Chinnery PF | 14/04/2022Initial Posting: February 27, 2014; Last Update: April 14, 2022. Clinical characteristics. Hereditary myopathy with early respiratory failure (HMERF) is a slowly progressive myopathy that typically begins in the third to fifth decades of l[...]Article
Comella M ; Collotta A ; Pavone V ; Ciccia L ; Bellinvia A ; Cerruto C ; Biondi MGL ; Pisani F ; Pavone P | 11/04/2022Article
Hershberger RE ; Jordan E | 07/04/2022Initial Posting: July 27, 2007; Last Update: April 7, 2022. The purpose of this overview is to increase clinician awareness of the genetic basis of dilated cardiomyopathy (DCM) and the benefits of early diagnosis and management to individuals[...]Article
Yalcouye A ; Diallo SH ; Cisse L ; Karembe M ; Diallo S ; Coulibaly T ; Diarra S ; Coulibaly D ; Keita M ; Guinto CO ; Fischbeck KH ; Wonkam A ; Landoure G | United States | 05/04/2022Article
Article
Benitez-Alonso EO ; Lopez-Hernandez JC ; Galnares-Olalde JA ; Alcala RE ; Vargas-Canas ES | 02/04/2022Article
Article
Article
Article
Baudou E ; Cances C ; Magdelaine C ; Latour P ; Louvier UW ; Juntas-Morales R ; Cintas P ; Rivier F | Germany | 16/03/2022Article
Article
Krenn M ; Tomschik M ; Wagner M ; Zulehner G ; Weng R ; Rath J ; Klotz S ; Gelpi E ; Bsteh G ; Keritam O ; Colonna I ; Paternostro C ; Jäger F ; Lindeck-Pozza E ; Iglseder S ; Grinzinger S ; Schönfelder M ; Hohenwarter C ; Freimüller M ; Embacher N ; Wanschitz J ; Topakian R ; Topf A ; Straub V ; Quasthoff S ; Zimprich F ; Loscher WN ; Cetin H | England | 03/03/2022Article
Grosz BR ; Stevanovski I ; Negri S ; Ellis M ; Barnes S ; Reddel S ; Vucic S ; Nicholson GA ; Cortese A ; Kumar KR ; Deveson IW ; Kennerson ML | United States | 28/02/2022Article
Zamani GR ; Mohammadi MF ; Tavasoli AR ; Ashrafi MR ; Hosseinpour S ; Ghabeli H ; Pourbakhtyaran E ; Haghighi R ; Hosseiny SMM ; Mohammadi P ; Heidari M | United States | 26/02/2022Article
Article
Benquey T ; Pion E ; Cossee M ; Krahn M ; Stojkovic T ; Perrin A ; Cerino M ; Molon A ; Lia AS ; Magdelaine C ; Francou B ; Guiochon-Mantel A ; Malinge MC ; LeGuern E ; Levy N ; Attarian S ; Latour P ; Bonello-Palot N | 09/02/2022Article
Pyromali I ; Benslimane N ; Favreau F ; Goizet C ; Lazaro L ; Vitry M ; Derouault P ; Sturtz F ; Magdelaine C ; Lia AS | 03/02/2022Article
Chia R ; Saez Atienzar S ; Murphy N ; Chio A ; Blauwendraat C ; Roda RH ; Tienari PJ ; Kaminski HJ ; Ricciardi R ; Guida M ; De Rosa A ; Petrucci L ; Evoli A ; Provenzano C ; Drachman DB ; Traynor BJ | United States | 01/02/2022Article
Pichette E ; O'Ferrall E ; Karamchandani J ; Savarese M ; Udd B ; Massie R | Netherlands | 29/01/2022Article
Article
Article
Initial Posting: September 5, 2000; Last Revision: January 20, 2022. Clinical characteristics. The dystrophinopathies cover a spectrum of X-linked muscle disease ranging from mild to severe that includes Duchenne muscular dystrophy, Becker[...]Article
Perez Siles G ; Ellis M ; Ashe A ; Grosz B ; Vucic S ; Kiernan MC ; Morris KA ; Reddel SW ; Kennerson ML | 19/01/2022Article
Article
Article
Schreuder AB ; Rossi A ; Grünert SC ; Derks TGJ | 06/01/2022Initial Posting: March 9, 2010; Last Update: January 6, 2022. Clinical characteristics. Glycogen storage disease type III (GSD III) is characterized by variable liver, cardiac muscle, and skeletal muscle involvement. GSD IIIa is the most c[...]Article
Article
Rodríguez Cruz PM ; Ravenscroft G ; Natera D ; Carr A ; Manzur A ; Liu WW ; Vella NR ; Jerico I ; Gonzalez-Quereda L ; Gallano P ; Montalto SA ; Davis MR ; Lamont PJ ; Laing NG ; Bourque P ; Nascimento A ; Muntoni F ; Polavarapu K ; Lochmuller H ; Palace J ; Beeson D | England | 2022Reco PNDS
Collectif | 01/2022Ce protocole national de diagnostic et de soins (PNDS) explicite aux professionnels concernés la prise en charge diagnostique et thérapeutique optimale et le parcours de soins d’un patient atteint de Dystrophie musculaire Facio-Scapulo-Scapulo-H[...]Article
Abicht A ; Müller J ; Lochmuller H | 23/12/2021Initial Posting: May 9, 2003; Last Update: December 23, 2021. The purpose of this overview is to increase the awareness of clinicians regarding congenital myasthenic syndromes (CMS) and their genetic causes and management. The following ar[...]Article
Goncalves A ; Fortuna A ; Ariyurek Y ; Oliveira ME ; Nadais G ; Pinheiro J ; den Dunnen JT ; Sousa M ; Oliveira J ; Santos R | 22/12/2021Article
Article
Gang Q ; Bettencourt C ; Brady S ; Holton JL ; Healy EG ; McConville J ; Morrison PJ ; Ripolone M ; Violano R ; Sciacco M ; Moggio M ; Mora M ; Mantegazza R ; Zanotti S ; Wang Z ; Yuan Y ; Liu WW ; Beeson D ; Hanna M ; Houlden H | United States | 15/12/2021Article
Gurunathan S ; Sebastian J ; Baker J ; Abdel Hamid HZ ; West SC ; Feingold B ; Peche V ; Reyes-Múgica M ; Madan-Khetarpal S ; Field J | United States | 04/12/2021Article
AlMuhaizea M ; Dabbagh O ; AlQudairy H ; AlHargan A ; Alotaibi W ; Sami R ; AlOtaibi R ; Ali MM ; AlHindi H ; Colak D ; Kaya N | 10/11/2021Article
Nous présentons le cas d’un patient de 45 ans, premier d’une fratrie de deux enfants issus de parents consanguins d’origine française.Article
Les rhabdomyolyses résultent d’un déséquilibre entre les besoins métaboliques et l’homéostasie énergétique de la cellule musculaire. Les causes génétiques de rhabdomyolyse sont liées à de multiples gènes.Article
Opal P | 14/10/2021Initial Posting: January 9, 2003; Last Update: October 14, 2021. Clinical characteristics. GAN-related neurodegeneration comprises a phenotypic continuum ranging from severe (sometimes called classic giant axonal neuropathy) to milder pure[...]Article
Ababneh NA ; Ali D ; Al-Kurdi B ; Barham R ; Bsisu IK ; Dababseh D ; Arafat S ; Khanfar AN ; Makahleh L ; Ryalat AT ; Sallam M ; El-Khateeb M ; Sharrack B ; Awidi A | Netherlands | 05/10/2021Article
Article
Article
Article
Article
Gurgel-Giannetti J ; Souza LS ; Messina de Pádua Andrade GF ; Derlene MF ; Meira ZMA ; Azevedo BVM ; Jr WC ; Diniz SSL ; Carvalhais MB ; Oliveira JRS ; Uliana L ; Bráulio R ; Costa PHN ; Filho GB ; Vainzof M | England | 21/09/2021Article
Biancalana V ; Rendu J ; Chaussenot A ; Mecili H ; Bieth E ; Fradin M ; Mercier S ; Michaud M ; Nougues MC ; Pasquier L ; Sacconi S ; Romero NB ; Marcorelles P ; Authier FJ ; Gelot Bernabe A ; Uro-Coste E ; Cances C ; Isidor B ; Magot A ; Minot-Myhie MC ; Pereon Y ; Perrier-Boeswillwald J ; Bretaudeau G ; Dondaine N ; Bouzenard A ; Pizzimenti M ; Eymard B ; Ferreiro A ; Laporte J ; Fauré J ; Bohm J | 17/09/2021Article
Suetterlin K ; Matthews E ; Sud R ; McCall S ; Fialho D ; Burge J ; Jayaseelan D ; Haworth A ; Sweeney MG ; Kullmann DM ; Schorge S ; Hanna MG ; Männikkö R | England | 16/09/2021Article
Alonso Perez J ; Gonzalez-Quereda L ; Bruno C ; Panicucci C ; Alavi A ; Nafissi S ; Nilipour Y ; Zanoteli E ; de Augusto Isihi LM ; Melegh B ; Hadzsiev K ; Muelas N ; Vilchez JJ ; Dourado ME ; Kadem N ; Kutluk G ; Umair M ; Younus M ; Pegorano E ; Bello L ; Crawford TO ; Suarez-Calvet X ; Topf A ; Guglieri M ; Marini-Bettolo C ; Gallano P ; Straub V ; Diaz-Manera J | England | 13/09/2021Article
Alghamdi F ; Al-Tawari A ; Alrohaif H ; Alshuaibi W ; Mansour H ; Aartsma Rus A ; Mégarbané A | 13/09/2021Article
Article
Article
Initial Posting: June 8, 2000; Last Update: July 29, 2021.Article
Baumbach-Reardon L ; Hunter JM ; Ahearn ME ; Pfautsch M | 29/07/2021Initial Posting: October 30, 2008; Last Update: July 29, 2021.Article
Article
Weber F | 01/07/2021Initial Posting: July 18, 2003; Last Update: July 1, 2021. Clinical characteristics. Hyperkalemic periodic paralysis (hyperPP) is characterized by attacks of flaccid limb weakness (which may also include weakness of the muscles of the eyes[...]Article
Uchôa Cavalcanti EB ; Santos SCL ; Martins CES ; de Carvalho DR ; Rizzo IMPO ; Freitas MCDNB ; da Silva Freitas D ; de Souza FS ; Junior AM ; do Nascimento OJM | United States | 30/06/2021Article
Article
Malfatti E ; Catchpool T ; Nouioua S ; Sihem H ; Fournier E ; Carlier RY ; Cardone N ; Davis MR ; Laing NG ; Sternberg D ; Ravenscroft G | England | 23/06/2021Article
Bos JW ; Groen EJN ; Wadman RI ; Curial CAD ; Molleman NN ; Zegers M ; van Vught PWJ ; Snetselaar R ; Vijzelaar R ; van der Pol WL ; van den Berg LH | 22/06/2021Article
Botta A ; Visconti VV ; Fontana L ; Bisceglia P ; Bengala M ; Massa R ; Bagni I ; Cardani R ; Sangiuolo F ; Meola G ; Antonini G ; Petrucci A ; Pegoraro E ; D'Apice MR ; Novelli G | 21/06/2021Article
Article
Che WI ; Westerlind H ; Lundberg IE ; Hellgren K ; Kuja-Halkola R ; Holmqvist M | England | 15/06/2021Article
Creary LE ; Gangavarapu S ; Caillier SJ ; Cavalcante P ; Frangiamore R ; Lie BA ; Bengtsson M ; Harbo HF ; Brauner S ; Hollenbach JA ; Oksenberg JR ; Bernasconi P ; Maniaol AH ; Hammarström L ; Mantegazza R ; Fernández-Viña MA | 07/06/2021Article
Topf A ; Pyle A ; Griffin H ; Matalonga L ; Schon K ; Sickmann A ; Schara Schmidt U ; Hentschel A ; Chinnery PF ; Kolbel H ; Roos A ; Horvath R | England | 01/06/2021Article
Matalonga L ; Hernandez-Ferrer C ; Piscia D ; Schule R ; Synofzik M ; Topf A ; Vissers LELM ; de Voer R ; Tonda R ; Laurie S ; Fernandez-Callejo M ; Picó D ; Garcia-Linares C ; Papakonstantinou A ; Corvo A ; Joshi R ; Diez H ; Gut I ; Hoischen A ; Graessner H ; Beltran S | England | 01/06/2021Article
Aoki M ; Takahashi T | 27/05/2021Initial Posting: February 5, 2004; Last Update: May 27, 2021. Clinical characteristics. Dysferlinopathy includes a spectrum of muscle disease characterized by two major phenotypes: Miyoshi muscular dystrophy (MMD) and limb-girdle muscular [...]Article
Article
Article
Takizawa H ; Mori Yoshimura M ; Minami N ; Murakami N ; Yatabe K ; Taira K ; Hashimoto Y ; Aoki Y ; Nishino I ; Takahashi Y | England | 27/04/2021Article
Initial Posting: June 11, 2015; Last Update: April 8, 2021 Clinical description. Riboflavin transporter deficiency (RTD), comprising RTD2 and RTD3 (caused by biallelic pathogenic variants in SLC52A2 and SLC52A3, respectively) is a rare neu[...]Article
Kutluk MG ; Kadem N ; Bektas O ; Randa NC ; Tuncer GO ; Albayrak P ; Eminoglu T ; Teber ST | 04/2021Article
Foley AR ; Mohassel P ; Donkervoort S ; Bolduc V ; Bonnemann CG | 11/03/2021Initial Posting: June 25, 2004; Last Update: March 11, 2021. Clinical characteristics. Collagen VI-related dystrophies (COL6-RDs) represent a continuum of overlapping clinical phenotypes with Bethlem muscular dystrophy at the milder end, U[...]Article
Azzedine H ; Salih MA | 11/03/2021Initial Posting: March 31, 2008; Last Update: March 11, 2021. Clinical characteristics. SH3TC2-related hereditary motor and sensory neuropathy (SH3TC2-HMSN) is a demyelinating neuropathy characterized by severe spine deformities (scoliosis[...]Article
Initial Posting: August 3, 2005; Last Update: February 25, 2021. Clinical characteristics. Myotonia congenita is characterized by muscle stiffness present from childhood; all striated muscle groups including the extrinsic eye muscles, faci[...]Article
Yalcintepe S ; Gurkan H ; Gungor Dogan I ; Demir S ; Ozemri Sag S ; Manav Kabayegit Z ; Atli EI ; Atli E ; Eker D ; Temel SG | Turkey | 22/02/2021Article
Lemmers RJLF ; van der Vliet PJ ; Blatnik A ; Balog J ; Zidar J ; Henderson D ; Goselink R ; Tapscott SJ ; Voermans NC ; Tawil R ; Padberg GWAM ; van Engelen BG ; van der Maarel SM | England | 12/01/2021Article
Kohlschmidt N ; Elbracht M ; Czech A ; Häusler M ; Phan V ; Topf A ; Huang KT ; Bartok A ; Eggermann K ; Zippel S ; Eggermann T ; Freier E ; Gross C ; Lochmuller H ; Horvath R ; Hajnoczky G ; Weis J ; Roos A | England | 11/01/2021Article
Velez-Bartolomei F ; Lee C ; Enns G | 07/01/2021Initial Posting: June 3, 2003; Last Update: January 7, 2021. Clinical characteristics. MERRF (myoclonic epilepsy with ragged red fibers) is a multisystem disorder characterized by myoclonus (often the first symptom) followed by generalized[...]Article
Prior TW ; Leach ME ; Finanger E | 3/12/2020Initial Posting: February 24, 2000; Last Revision: December 3, 2020. Clinical characteristics. Spinal muscular atrophy (SMA) is characterized by muscle weakness and atrophy resulting from progressive degeneration and irreversible loss of t[...]Article
Trollet C ; Boulinguiez A ; Roth F ; Stojkovic T ; Butler Browne G ; Evangelista T ; Lacau St Guily J ; Richard P | 22/10/2020Initial Posting: March 8, 2001; Last Update: October 22, 2020. Clinical characteristics. Oculopharyngeal muscular dystrophy (OPMD) is characterized by ptosis and dysphagia due to selective involvement of the muscles of the eyelids and phar[...]Article
McCray BA ; Schindler A ; Hoover-Fong JE ; Sumner CJ | 17/09/2020Initial Posting: May 15, 2014; Last Update: September 17, 2020. Clinical characteristics. The autosomal dominant TRPV4 disorders (previously considered to be clinically distinct phenotypes before their molecular basis was discovered) are n[...]Article
Initial Posting: April 2, 2009; Last Update: September 17, 2020. Clinical characteristics. Most individuals with classic GBE1 adult polyglucosan body disease (GBE1-APBD) present after age 40 years with unexplained progressive neurogenic bl[...]Article
Oliveira J ; Parente Freixo J ; Santos M ; Coelho T | 17/09/2020Initial Posting: June 7, 2012; Last Update: September 17, 2020. Clinical characteristics. The clinical manifestations of LAMA2 muscular dystrophy (LAMA2-MD) comprise a continuous spectrum ranging from severe congenital muscular dystrophy t[...]Article
Chrestian N | 27/08/2020Initial Posting: September 28, 1998; Last Update: August 27, 2020. Clinical characteristics. Hereditary neuropathy with liability to pressure palsies (HNPP) is characterized by recurrent acute sensory and motor neuropathy in a single or mu[...]Article
Ferreira C ; Pierre G ; Thompson R ; Vernon H | 09/07/2020nitial Posting: October 9, 2014; Last Update: July 9, 2020. Clinical characteristics. Barth syndrome is characterized in affected males by cardiomyopathy, neutropenia, skeletal myopathy, prepubertal growth delay, and distinctive facial ges[...]Article
Deng J ; Yu J ; Li P ; Luan X ; Cao L ; Zhao J ; Yu M ; Zhang W ; Lv H ; Xie Z ; Meng L ; Zheng Y ; Zhao Y ; Gang Q ; Wang Q ; Liu J ; Zhu M ; Guo X ; Su Y ; Liang Y ; Liang F ; Hayashi T ; Maeda MH ; Sato T ; Ura S ; Oya Y ; Ogasawara M ; Iida A ; Nishino I ; Zhou C ; Yan C ; Yuan Y ; Hong D ; Wang Z | United States | 07/2020Article
Prasun P | 18/06/2020Clinical characteristics. Multiple acyl-CoA dehydrogenase deficiency (MADD) represents a clinical spectrum in which presentations can be divided into type I (neonatal onset with congenital anomalies), type II (neonatal onset without congenita[...]Article
Echaniz-Laguna A ; Biancalana V ; Nadaj-Pakleza A ; Fournier E ; Matthews E ; Hanna MG ; MÀnnikkà R | England | 06/2020Article
Article
Article
Benquey T ; Fockens E ; Kouton L ; Delmont E ; Martini N ; Levy N ; Attarian S ; Bonello-Palot N | Netherlands | 06/2020Article
Gharesouran J ; Jalaiei A ; Hosseinzadeh A ; Ghafouri-Fard S ; Mokhtari Z ; Ghahremanzadeh K ; Rezazadeh N ; Shiva S ; Sadeghvand S ; Taheri M ; Rezazadeh M | United States | 06/2020Article
Hamanaka K ; Sikrova D ; Mitsuhashi S ; Masuda H ; Sekiguchi Y ; Sugiyama A ; Shibuya K ; Lemmers RJLF ; Goossens R ; Ogawa M ; Nagao K ; Obuse C ; Noguchi S ; Hayashi YK ; Kuwabara S ; Balog J ; Nishino I ; van der Maarel SM | United States | 06/2020Article
Zuchner S | 14/05/2020Initial Posting: February 18, 2005; Last Update: May 14, 2020. Clinical characteristics. MFN2 hereditary motor and sensory neuropathy (MFN2-HMSN) is a classic axonal peripheral sensorimotor neuropathy, inherited in either an autosomal domi[...]Article
Article
Article
Rodolico C ; Politano L ; Portaro S ; Murru S ; Boccone L ; Sera F ; Passamano L ; Brizzi T ; Tupler R | England | 05/2020Article
Gonzalez-Quereda L ; Rodriguez MJ ; Diaz-Manera J ; Alonso Perez J ; Gallardo E ; Nascimento A ; Ortez C ; Benito DN ; Olive M ; Gonzalez Mera L ; Munain AL ; Zulaica M ; Poza JJ ; Jerico I ; Torne L ; Riera P ; Milisenda J ; Sanchez A ; Garrabou G ; Llano I ; Madruga-Garrido M ; Gallano P | Switzerland | 05/2020Article
Lorenzoni PJ ; Kay CSK ; Arndt RC ; Hrysay NMC ; Ducci RD ; Fustes OHJ ; Topf A ; Lochmuller H ; Werneck LC ; Scola RH | Scotland | 05/2020Article
Zamani G ; Hosseini Bereshneh A ; Azizi Malamiri R ; Bagheri S ; Moradi K ; Ashrafi MR ; Tavasoli AR ; Mohammadi M ; Badv RS ; Ghahvechi Akbari M ; Heidari M | United States | 05/2020Article
Morizumi T ; Ueno A ; Takasone K ; Ozawa K ; Yoshinaga T ; Nakamura K ; Sekijima Y | Netherlands | 05/2020Article
Al-Muhaizea MA ; AlQuait L ; AlRasheed A ; AlHarbi S ; Albader AA ; AlMass R ; Albakheet A ; Alhumaidan A ; AlRasheed MM ; Colak D ; Kaya N | England | 05/2020Article
Carrillo N ; Malicdan MC ; Huizing M | 09/04/2020Initial Posting: March 26, 2004; Last Update: April 9, 2020. Clinical characteristics. GNE myopathy is a slowly progressive muscle disease that typically presents between age 20 and 40 years with bilateral foot drop caused by anterior tibial[...]Article
Article
Article
Ohkawara B ; Shen X ; Selcen D ; Nazim M ; Bril V ; Tarnopolsky MA ; Brady L ; Fukami S ; Amato AA ; Yis U ; Ohno K ; Engel AG | United States | 04/2020Article
Geroldi A ; Prada V ; Veneri F ; Trevisan L ; Origone P ; Grandis M ; Schenone A ; Gemelli C ; Lanteri P ; Fossa P ; Mandich P ; Bellone E | United States | 04/2020Article
Abdel Aleem A ; Elsaid MF ; Chalhoub N ; Chakroun A ; Mohamed KAS ; AlShami R ; Kuzu O ; Mohamed RB ; Ibrahim K ; AlMudheki N ; Osman O ; Ross ME ; ELalamy O | England | 04/2020Article
Keller N ; Mendoza-Ferreira N ; Maroofian R ; Chelban V ; Khalil Y ; Mills PB ; Boostani R ; Torbati PN ; Karimiani EG ; Thiele H ; Houlden H ; Wirth B ; Karakaya M | England | 04/2020Article
Lee CY, Auteur ; Petkova M ; Morales-Gonzalez S ; Gimber N ; Schmoranzer J ; Meisel A ; Bohmerle W ; Stenzel W ; Schuelke M ; Schwarz JM | England | 04/2020Article
Vanherpe P ; Fieuws S ; D'Hondt A ; Bleyenheuft C ; Demaerel P ; De Bleecker J ; van den Bergh P ; Baets J ; Remiche G ; Verhoeven K ; Delstanche S ; Toussaint M ; Buyse B ; Van Damme P ; Depuydt CE ; Claeys KG | 04/2020Article
Schoser B | 19/03/2020Initial Posting: September 21, 2006; Last Update: March 19, 2020. Clinical characteristics. Myotonic dystrophy type 2 (DM2) is characterized by myotonia and muscle dysfunction (proximal and axial weakness, myalgia, and stiffness), and less[...]Article
Article
El Kadiri Y ; Selouani Y ; Ratbi I ; Lyahyai J ; Zrhidri A ; Sahli M ; Ouhenach M ; Jaouad IC ; Sefiani A ; Sbiti A | Netherlands | 03/2020Article
Article
Article
Joosten IBT ; Hellebrekers DMEI ; de Greef BTA ; Smeets HJM ; De Die-Smulders CEM ; Faber CG ; Gerrits MM | England | 03/2020Article
Neri M ; Rossi R ; Trabanelli C ; Mauro A ; Selvatici R ; Falzarano MS ; Spedicato N ; Margutti A ; Rimessi P ; Fortunato F ; Fabris M ; Gualandi F ; Comi G ; Tedeschi S ; Seia M ; Fiorillo C ; Traverso M ; Bruno C ; Giardina E ; Piemontese MR ; Merla G ; Cau M ; Marica M ; Scuderi C ; Borgione E ; Tessa A ; Astrea G ; Santorelli FM ; Merlini L ; Mora M ; Bernasconi P ; Gibertini S ; Sansone V ; Mongini T ; Berardinelli A ; Pini A ; Liguori R ; Filosto M ; Messina S ; Vita G ; Toscano A ; Vita G ; Pane M ; Servidei S ; Pegoraro E ; Bello L ; Travaglini L ; Bertini E ; D'Amico A ; Ergoli M ; Politano L ; Torella A ; Nigro V ; Mercuri E ; Ferlini A | 03/2020Article
Article
Article
Abrams CK | 20/02/2020Initial Posting: June 18, 1998; Last Update: February 20, 2020. Clinical characteristics. GJB1 disorders are typically characterized by peripheral motor and sensory neuropathy with or without fixed CNS abnormalities and/or acute, self-limite[...]Article
Preston MK ; Tawil R ; Wang LH | 06/02/2020Initial Posting: March 8, 1999; Last Update: February 6, 2020. Clinical characteristics. Facioscapulohumeral muscular dystrophy (FSHD) typically presents with weakness of the facial muscles, the stabilizers of the scapula, or the dorsiflexor[...]Article
Article
Rosenberg H ; Sambuughin N ; Riazi S ; Dirksen R | 16/01/2020Initial Posting: December 19, 2003; Last Update: January 16, 2020. Clinical characteristics. Malignant hyperthermia susceptibility (MHS) is a pharmacogenetic disorder of skeletal muscle calcium regulation associated with uncontrolled skeleta[...]Article
Initial Posting: February 17, 2005; Last Update: January 2, 2020. Clinical characteristics. Udd distal myopathy – tibial muscular dystrophy (UDM-TMD) is characterized by weakness of ankle dorsiflexion and inability to walk on the heels aft[...]Article
Bevilacqua JA ; Guecaimburu Ehuletche MDR ; Perna A ; Dubrovsky A ; Franca MC Jr ; Vargas S ; Hegde M ; Claeys KG ; Straub V ; Daba N ; Faria R ; Periquet M ; Sparks S ; Thibault N ; Araujo R | England | 01/2020Article
Article
Article
Akesson LS ; Savarirayan R | 2020Clinical characteristics. Fibrodysplasia ossificans progressiva (FOP) is characterized by congenital bilateral hallux valgus malformations and early-onset heterotopic ossification, which may be spontaneous or precipitated by trauma including [...]Article
Landires I ; Nunez-Samudio V ; Fernandez J ; Sarria C ; Villareal V ; Cordoba F ; Apraez-Ippolito G ; Martinez S ; Vidal OM ; Velez JI ; Arcos-Holzinger M ; Landires S ; Arcos-Burgos M | Switzerland | 01/2020Article
Topf A ; Johnson K ; Bates A ; Phillips L ; Chao KR ; England EM ; Laricchia KM ; Mullen T ; Valkanas E ; Xu L ; Bertoli M ; Blain A ; Casasus AB ; Duff J ; Mroczek M ; Specht S ; Lek M ; Ensini M ; Macarthur DG ; Straub V | United States | 2020Article
Forrester N ; Rattihalli R ; Horvath R ; Maggi L ; Manzur A ; Fuller G ; Gutowski N ; Rankin J ; Dick D ; Buxton C ; Greenslade M ; Majumdar A | Netherlands | 2020Article
Muller Felber W ; Vill K ; Schwartz O ; Glaser D ; Nennstiel U ; Wirth B ; Burggraf S ; Roschinger W ; Becker M ; Durner J ; Eggermann K ; Muller C ; Hannibal I ; Olgemoller B ; Schara U ; Blaschek A ; Kolbel H | Netherlands | 2020Article
[Republished online : 2021 May 13];[Published online : 2020 Dec 7] »Article
Gentile L ; Russo M ; Fabrizi GM ; Taioli F ; Ferrarini M ; Testi S ; Alfonzo A ; Aguennouz M ; Toscano A ; Vita G ; Mazzeo A | Italy | 01/2020Article
Cortese A ; Wilcox JE ; Polke JM ; Poh R ; Skorupinska M ; Rossor AM ; Laura M ; Tomaselli PJ ; Houlden H ; Shy ME ; Reilly MM | United States | 01/2020